Article, page-2

The article also appears in other Fairfax newspapers and web-sites today including The Age and Sydney Morning Herald.

It's at least a relatively balanced article on the MM industry.

I tend to agree with the article that a lot of the hype has gone from the MM stocks, and that most MM stocks should see steady SP growth with milestones such as clinical trials, product deals, revenue and ultimately profits.

I think AC8 and some of the other stocks are a long-term investment of 2-3 years minimum. Most of the day traders and short-term investors have probably turned their attention to other stocks and sectors now.

It will be interesting to see if the previous hype will return to MM stocks with upcoming floats in the next 2 weeks.

GLTAH.